Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Firivumab (DVV03802)

Host species:Homo sapiens
Isotype:IgG1, kappa
Applications:Research Grade Biosimilar
Expression system:XtenCHO
Overview

Catalog No.

DVV03802

Host species

Homo sapiens

Species reactivity

Influenza A virus

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Concentration

1 mg/ml

Purity

>95% by SDS-PAGE.

Clonality

Monoclonal

Isotype

IgG1, kappa

Applications

Research Grade Biosimilar

Target

HA/Hemagglutinin

Purification

Protein A or G purified from cell culture supernatant.

Endotoxin level

Please contact with the lab for this information.

Expression system

XtenCHO

Accession

P03455

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Alternative Names

CT-P22, CAS: 1443004-15-6, Influenza Virus (Flu)

Note

For research use only. Not suitable for clinical or therapeutic use.

Data Image
  • SDS-PAGE
    SDS PAGE for Firivumab
References

A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome, PMID: 30001986

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies, PMID: 29707140

A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies, PMID: 32601377

High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals, PMID: 28723950

Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma, PMID: 30828910

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies, PMID: 24326534

How to outsmart NK cell tolerance, PMID: 26405590

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy, PMID: 24701370

Datasheet

Document Download

Research Grade Firivumab.pdf

 

$ 328
Product specifications
100 μg 328 1 mg 1314

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Firivumab [DVV03802]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only